| |
CLINICAL TRIALS
If you are one of the people diagnosed with
mesothelioma each year, clinical trials may offer the best available treatment
and the opportunity to receive new, potentially more effective therapy. MesotheliomaHelp.net has provided the following
information regarding clinical trials to help you locate resources for new
mesothelioma treatments. Please contact the individual treatment centers for
more information about participation.
|
Title:
ALIMTA (pemetrexed) Plus Gemcitabine (Gemzar) for
Patients with Malignant Pleural or Peritoneal Mesothelioma who have not had
previous chemotherapy |
Posted:
3/25/04
More Information > |
There may be multiple sites in this clinical trial including: Colorado,
Florida, Illinois, Maryland, Massachusetts, Michigan, New Mexico, New York,
Ohio, Pennsylvania, and Wisconsin. |
|
Title:
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural
or Peritoneal Mesothelioma who have had no more than one prior chemotherapy |
|
Title:
Open-Label Study of ALIMTA (pemetrexed) in Combination with Cisplatin for
Chemonaive Patients with Malignant Pleural Mesothelioma |
|
Posted:
3/25/04
More Information > |
The purpose of this protocol is to extend the clinical experience with ALIMTA
plus cisplatin in patients with malignant pleural mesothelioma and to collect
additional safety information in this patient population. |
|
Title:
Phase II trial of combined resection, intraperitoneal chemotherapy, and whole
abdominal radiation for treatment of peritoneal mesothelioma |
|
Title:
Phase II trial of perioperative gemcitabine and cisplatin chemotherapy in
resected pleural mesothelioma |
|
Posted:
3/25/04
More Information > |
Eligibility Requirements:
Histologically confirmed malignant pleural mesothelioma
No prior chemotherapeutic regimens |
|
Title:
Trimodal Therapy, Phase II trial of combined resection, intraperitoneal
chemotherapy, and whole abdominal radiation in peritoneal mesothelioma |
|
Posted:
3/25/04
More Information > |
Columbia University Hospital / Cancer Center at
Columbia University: New York, NY |
|
Title:
Phase II Study of Neoadjuvant Pemetrexed Disodium and Cisplatin Followed By
Extrapleural Pneumonectomy and Radiotherapy in Patients With Stage I, II, or
III Pleural Mesothelioma |
|
Posted:
3/25/04
More Information > |
Memorial Sloan-Kettering Cancer Center. Study Sites
in Boston, MA and New York, NY. |
----------------------
The following websites provide lists of clinical trials for mesothelioma
sufferers:
National Cancer Institute's Clinical Trials Finder
ClinicalTrials.gov: Mesothelioma Trials
CenterWatch: Clinical Trials Listing Service
Eli Lilly Mesothelioma Clinical Trials
|
|
|
 |
| |
To request a free case
evaluation, please complete
the following: |
|
|
|
|
|
